Cengild Medical Berhad (KLSE:CENGILD)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.205
0.00 (0.00%)
At close: Apr 28, 2026
-16.33%
Market Cap 174.91M
Revenue (ttm) 74.93M
Net Income (ttm) 9.69M
Shares Out 832.91M
EPS (ttm) 0.01
PE Ratio 15.72
Forward PE n/a
Dividend 0.01 (4.73%)
Ex-Dividend Date Feb 25, 2026
Volume 132,900
Average Volume 349,530
Open 0.205
Previous Close 0.205
Day's Range 0.205 - 0.210
52-Week Range 0.200 - 0.275
Beta 0.06
RSI 50.46
Earnings Date May 28, 2026

About Cengild Medical Berhad

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiology; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric su... [Read more]

Industry Health Services
Founded 2017
Employees 151
Stock Exchange Bursa Malaysia
Ticker Symbol CENGILD
Full Company Profile

Financial Performance

In fiscal year 2025, Cengild Medical Berhad's revenue was 80.00 million, an increase of 19.72% compared to the previous year's 66.82 million. Earnings were 11.06 million, a decrease of -0.19%.

Financial Statements

News

There is no news available yet.